Compare Workiva Inc (WK) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Workiva Inc vs State Street SPDR S&P Biotech ETF — how do they compare? Workiva Inc trades at $55.02 (market cap $3.21B), while State Street SPDR S&P Biotech ETF trades at $154.49. The key difference: State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Workiva Inc nearer its low. Which is the better fit depends on your goals.
| WK | XBI | |
|---|---|---|
Market Cap | $3.21B | — |
Sector | Technology | Broad Market / Factor |
52-Week High | $93.31 | $164.28 |
52-Week Low | $44.31 | $85.16 |
Enterprise Value | $3.14B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Workiva Inc
Workiva is a leading provider of cloud-based platforms for complex reporting and compliance. It enables organizations to connect and manage data across financial reporting, ESG (Environmental, Social, and Governance), and GRC (Governance, Risk, and Compliance), serving as a single source of truth for auditable, transparent disclosures to regulators and stakeholders.
Read more on WK →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
